Springer Nature
Browse
12933_2017_529_MOESM1_ESM.doc (379 kB)

MOESM1 of Effects of the SGLT2 inhibitor dapagliflozin on HDL cholesterol, particle size, and cholesterol efflux capacity in patients with type 2 diabetes: a randomized placebo-controlled trial

Download (379 kB)
journal contribution
posted on 2017-04-04, 05:00 authored by Gian Fadini, Benedetta Bonora, Giancarlo Zatti, Nicola Vitturi, Elisabetta Iori, Maria Marescotti, Mattia Albiero, Angelo Avogaro
Additional file 1. Supplemental data on cholesterol efflux capacity and bioimpedance vector analysis.

Funding

AstraZeneca

History

Usage metrics

    Cardiovascular Diabetology

    Categories

    Keywords

    AtherosclerosisBody compositionTherapy

    Licence

    CC BY + CC0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC